Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02828553 · ClinicalTrials.gov registry record
CHF Inpatient Ambulation Trial
A clinical trial of Heart Failure, sponsored by Lancaster General Hospital.
- Completed
- Registry status
- 352
- Enrollment target
- 1
- Study location
NCT02828553: Completed study of Heart Failure, sponsored by Lancaster General Hospital.
NCT02828553 is a study of Heart Failure that has completed, run by Lancaster General Hospital. The registered enrollment target is 352 participants, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02828553, a study of Heart Failure, has completed, sponsored by Lancaster General Hospital.
- COMPLETED
- Registry status
- 352 participants
- Enrollment target
- 1
- Study location
Study Summary
There is an overwhelming amount of deconditioning that occurs during the hospitalization to a patient admitted with a primary diagnosis of congestive heart failure. The goals of this study are to determine if monitored activity and aggressive mobility provides improved outcomes in hospitalized heart failure patients.
Primary Outcome
Walk distance using a 2-minute walk test will be assessed at admission and again at discharge. A clear starting and stopping point will be made with distance marked every 10 feet. A chair with armrests will be at the starting and stopping point of the walk distance. The designated area will be between 5 East and 5 West which will be standard for each patient. After the assessment the nurse will document the total patient's distance to the nearest 10 feet. Example "Ms. Smith walked 100 feet with
Conditions Studied
Interventions
- OTHER Aggressive planned ambulation with a mobility aide
Study Locations (1)
Pennsylvania
- Lancaster General Hospital - Lancaster
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 352 participants |
| Start Date | 2016-10 |
| Est. Completion | 2018-12-31 |
What the finished NCT02828553 record still lists
NCT02828553 is an observational study that tracks outcomes without assigning an intervention. The registered 352 participants enrollment target is mid-sized for trials with a published cap, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Aggressive planned ambulation with a mobility aide is the first listed.
NCT02828553 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02828553 about?
NCT02828553 is a clinical study titled "CHF Inpatient Ambulation Trial". There is an overwhelming amount of deconditioning that occurs during the hospitalization to a patient admitted with a primary diagnosis of congestive heart failure. The goals of this study are to determine if monitored activity and aggressive mobility provides improved outcomes in hospitalized heart...
What is the current status of trial NCT02828553?
This trial is currently completed. The enrollment target is 352 participants. The study started on 2016-10. Estimated completion is 2018-12-31.
What conditions does trial NCT02828553 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT02828553?
The interventions under investigation include: Aggressive planned ambulation with a mobility aide (OTHER).
Who is sponsoring clinical trial NCT02828553?
This trial is sponsored by Lancaster General Hospital, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02828553 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02828553's enrollment target sits among peer trials
352 127th of 397 higher than 271 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05811936 · 352 participants · NA
The SNAP Tool for Head and Neck Cancer Survivor-Caregiver Dyads
- NCT06258941 · 352 participants · Phase 1
Classroom Break, Cognition, and Fitness in Elementary School Children
- NCT06269081 · 352 participants · NA
Testing Two Interventions to Improve Health Outcomes and Quality of Life Among Rural Older Adults Living With HIV
- NCT06337292 · 352 participants · Phase 3
Incisional Negative Pressure Wound Therapy to Reduce Infection and Complications in High-Risk Fractures
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia